Ultrastructural observations on the marine fouling diatomAmphora

Ecological and Scanning electron microscope (S. E. M.) studies indicated that the diatomAmphora was an important constituent in the initial colonization of test panels coated with a copper antifouling composition.Amphora was also found as the dominant fouling diatom species on paint samples from in-service supertankers and yachts. Associated with the diatom was copious amounts of mucilaginous material, which often encapsulated the cells. Histochemical analysis of the mucilage indicates that it is predominantly polysaccharide in nature. Using the Transmission electron microscope (T. E. M.) and electron microscope cytochemistry the intracellular origin of the adhesive was investigated. T. E. M. and S. E. M. observations of acid-cleaned-cells indicate that the mucilage may be secreted through specialized regions of the frustule. Material isolated from antifouling panels was compared with laboratory culturedAmphora spp. for copper resistance and internal accumulation using TEMSCAN — X ray analytical equipment.     

Glycosidases of marine organisms

This review discusses the catalytic properties, activity regulation, structure, and functions of O-glycoside hydrolases from marine organisms exemplified by endo-1→3-β-D-glucanases of marine invertebrates.     

Inhibition of fouling by marine bacteria immobilised in kappa-carrageenan beads

Antifouling solutions that leave little or no impact in the world's oceans are constantly being sought. This study employed the immobilisation of the antifouling bacterium Pseudoalteromonas tunicata in kappa-carrageenan to demonstrate how a surface may be protected from fouling by bacteria, i.e. a 'living paint'. Attempts so far to produce a 'living paint' have been limited in both longevity of effectiveness and demonstration of applicability, most noticeably regarding the lack of any field data. Here survival of bacteria immobilised in kappa-carrageenan for 12 months in the laboratory is demonstrated and evidence presented for inhibition of fouling for up to 7 weeks in the field (Sydney Harbour, NSW, Australia).     

Cyclosporin A inhibits creatine uptake by altering surface expression of the creatine transporter

The immunosuppressive drug cyclosporin A (CsA) inhibited the hCRT-1 cDNA-induced creatine uptake in Xenopus oocytes and the endogenous creatine uptake in cultured C(2)C(12) muscle cells in a dose- and time-dependent manner. FK506, another potent immunosuppressant, was unable to mimic the effect of CsA suggesting that the inhibitory effect of CsA was specific. To delineate the mechanism underlying, we investigated the effect of CsA on the K(m) and V(max) of creatine transport and also on the cell surface distribution of the creatine transporter. Although CsA treatment did not affect the K(m) (20-24 microm) for creatine, it significantly decreased the V(max) of creatine uptake in both oocytes and muscle cells. CsA treatment reduced the cell surface expression level of the creatine transporter in the muscle cells by approximately 60% without significantly altering its total expression level, and the reduction in the cell surface expression paralleled the decrease in creatine uptake. Taken together, our results suggest that CsA inhibited creatine uptake by altering the surface abundance of the creatine transporter. We propose that CsA impairs the targeting of the creatine transporter by inhibiting the function of an associated cyclophilin, resulting in an apparent loss in surface expression of the creatine transporter. Our results also suggest that prolonged exposure to CsA may result in chronically creatine-depleted muscle, which may be a cause for the development of CsA-associated clinical myopathies in organ transplant patients.     

Sphingosine inhibits monocyte tissue factor-initiated coagulation by altering factor VII binding

Tissue factor is a lipoprotein, expressed on the surface of cells, which binds coagulation Factor VII or VIIa, leading to activation of Factors X and IX with subsequent fibrin generation. Cellular tissue factor activity is important in pathophysiologic processes such as inflammation and disseminated intravascular coagulation. In this study, the long-chain base sphingosine inhibited coagulation initiated by lipopolysaccharide-stimulated intact human monocytes. Sphingosine (5-100 microM) also profoundly inhibited thromboplastin-initiated coagulation (greater than 90% decrease in thromboplastin activity). This inhibition was dose- and time-dependent. Sphingosine inhibited neither the intrinsic pathway of coagulation nor thrombin generation of fibrin. The sphingosine analogues sphingomyelin, ceramide, or N-acetylsphingosine did not affect thromboplastin activity, suggesting that the polar head of sphingosine was necessary for interaction of the molecule with the coagulation system. Investigation of the biochemical mechanism revealed that sphingosine (5-50 microM), but neither sphingomyelin nor ceramide, inhibited specific binding of radiolabeled Factor VII to lipopolysaccharide-stimulated intact monocytes. The results suggest that sphingosine may regulate monocyte tissue factor-initiated coagulation by modulating Factor VII binding to tissue factor. Sphingosine may represent a new class of inhibitors of hemostasis.     

Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation

Contact of developing sensory organs with the external environment is established via the formation of openings in the skin. During eye development, eyelids first grow, fuse and finally reopen, thus providing access for visual information to the retina. Here, we show that eyelid opening is strongly inhibited in transgenic mice overexpressing the bone morphogenetic protein (BMP) antagonist noggin from the keratin 5 (K5) promoter in the epidermis. In wild-type mice, enhanced expression of the kinase-inactive form of BMPR-IB mediated by an adenovirus vector also inhibits eyelid opening. Noggin overexpression leads to reduction of apoptosis and retardation of cell differentiation in the eyelid epithelium, which is associated with downregulation of expression of the apoptotic receptors (Fas, p55 kDa TNFR), Id3 protein and keratinocyte differentiation markers (loricrin, involucrin). BMP-4, but not EGF or TGF-alpha, accelerates opening of the eyelid explants isolated from K5-Noggin transgenic mice when cultured ex vivo. These data suggest that the BMP signaling pathway plays an important role in regulation of genetic programs of eyelid opening and skin remodeling during the final steps of eye morphogenesis.     

Adaptation capabilities of marine modular organisms

Marine modular organisms such as hydroids and coralsare plastic in their responses to continuouslychanging environments. Morphogenetic limitations areless important for modular animals and plants, thanfor unitary ones. Although each module variesrelatively little, modular organisms are characterizedby an extremely broad plasticity of shape. Sessilecolonial animals grow into a heterogenous environmentand so each modular organism has its own often uniqueshape. The mechanism of modular body plasticity andadaptation to the environment is based on cyclicalmorphogenesis through replication of modules.Plasticity of shape is achieved not only by colonialgrowth, but during unfavorable periods also by bodyreduction due to module reabsorbtion.     

On the origin of pristane in marine organisms

Phytol-U-(14)C was adsorbed on algae and ingested in this form by zooplanktonic copepods (two species of Calanus). The lipids of these animals were analyzed after 48 hr and found to contain radioactive pristane and radioactive phytanic acid. The conversion of phytol to pristane by the copepods is interpreted as a likely biological source of pristane in nature.     

Prospective of the cosmeceuticals derived from marine organisms

Cosmeceuticals, derived from the words ‘cosmetic and pharmaceutical’, have drug-like benefits and contain active ingredients such as vitamins, phytochemicals, enzymes, antioxidants, and essential oils. Cosmeceuticals have attracted increased attention because of their beneficial effects on human health. Bioactive substances derived from marine organisms have diverse functional roles as a secondary metabolite and these properties can be applied to the developments of novel pharmaceuticals and cosmeceuticals. Recently, extensive studies have been conducted on the general aspects of the chemical structures, physical and biochemical properties, and biotechnological applications of bioactive substances derived from marine organisms. In this review, we have discussed recent progresses in the biotechnological applications of bioactive substances from marine organisms as cosmeceuticals.     

Apolipoprotein A-I mimetic peptide inhibits atherosclerosis by altering plasma metabolites in hypercholesterolemia

An apolipoprotein A-I mimetic peptide, D-4F, has been shown to improve vasodilation and inhibit atherosclerosis in hypercholesterolemic low-density lipoprotein receptor-null (LDLr(-/-)) mice. To study the metabolic variations of D-4F ininhibiting atherosclerosis, metabonomics, a novel system biological strategy to investigate the pathogenesis, was developed. Female LDLr(-/-) mice were fed a Western diet and injected with or without D-4F intraperitoneally. Atherosclerotic lesion formation was measured, whereas plasma metabolic profiling was obtained on the basis of ultra-high-performance liquid chromatography in tandem with time-of-flight mass spectrometry operating in both positive and negative ion modes. Data were processed by multivariate statistical analysis to graphically demonstrate metabolic changes. The partial least-squares discriminate analysis model was validated with cross-validation and permutation tests to ensure the model's reliability. D-4F significantly inhibited the formation of atherosclerosis in a time-dependent manner. The metabolic profiling was altered dramatically in hypercholesterolemic LDLr(-/-) mice, and a significant metabolic profiling change in response to D-4F treatment was observed in both positive and negative ion modes. Thirty-six significantly changed metabolites were identified as potential biomarkers. A series of phospholipid metabolites, including lysophosphatidylcholine (LysoPC), lysophosphatidylethanolamine (LysoPE), phosphatidylcholine (PC), phatidylethanolamine (PE), sphingomyelin (SM), and diacylglycerol (DG), particularly the long-chain LysoPC, was elevated dramatically in hypercholesterolemic LDLr(-/-) mice but reduced by D-4F in a time-dependent manner. Quantitative analysis of LysoPC, LysoPE, PC, and DG using HPLC was chosen to validate the variation of these potential biomarkers, and the results were consistent with the metabonomics findings. Our findings demonstrated that D-4F may inhibit atherosclerosis by regulating phospholipid metabolites specifically by decreasing plasma long-chain LysoPC.     

Cryopreservation of the cells and larvae of marine organisms

This paper reviews original and literature data on the cryoresistance of the cells of marine organisms. The technology for the cryopreservation of these objects includes the selection of freezing conditions and the use, in addition to traditional cryoprotectants, of combinations of exogenous lipids, antioxidants, and disaccharide trehalose as a membrane stabilizing agent. We propose an approach for the preservation of marine invertebrate cells. The approach is based on the use of biologically active substances obtained from the tissues of marine organisms. Our results demonstrated the synergistic activity of these components of cryoprotective mixtures, and, at the same time, the specificity of antioxidant effects. An analysis of the factors that determine the choice of cryoprotectors was performed for various cell types. The development of the cryopreservation methods of marine organisms provides an opportunity for their wide application in both developmental biology and in marine biotechnology and serves as an important prerequisite for the cryobank creation.     

Effect of galvanically induced surface potentials on marine fouling

This paper reports the effect of a galvanically produced negative surface potential on the accumulation of marine biofouling. The potential was created by connecting pieces of copper or stainless steel to a layer of Indium/Tin Oxide semiconductor deposited on glass. It was shown that the negative potential significantly reduced the accumulation of biofouling. As the conductive layer is transparent, the technique was used to protect the windows of commercial optical instruments. This technology could provide an inexpensive way of extending deployment times for marine instruments.     

Chemical characterization of exopolysaccharides from the marine fouling diatom amphora coffeaeformis

Amphora coffeaeformis cells were grown in batch cultures under continuous illumination at 18°C for 10 d. Algal cells were removed by centrifugation, lyophilized and used for the extraction of exopolysaccharides using either 0.05 M EDTA, 1 M NaOH or 1.5 M NaCl. The 1.5 M NaCl treatment removed most exopolysaccharides. Glucose (81%) was the most abundant monosaccharide in the exopolysaccharides. The chemical composition data suggest that the exopolymers were acidic sulphated polysaccharides containing high concentrations of pyruvate (22%) and uronic acids (18%). These polysaccharides may play an important role in metal complexation and protection from desiccation in A. coffeaeformis.     

Regulation of intracellular lipid metabolism by the preparation of omega-3 phospholipids from marine organisms in deficiency of essential fatty acids in rats

It has been established that a deficit of essential fatty acids (EFA) in the animal organism induces specific modifications of composition of fatty acid (FA) of general phospholipids and plasmalogenic P1 in microsomal tissue membranes with various functions and affects the activity of phospholipase A2. It has been shown that arachidonic (AA), docosapentaenoic (DPA) and docosahexaenoic (DHA) acids in the composition of general phospholipids - phosphatidylcholine (PC), phosphatidylethanolamine (PEA) and plasmalogens PC and PEA react to EFA deficit in the organism. Quantitative redistribution of AA, DPA, DHA of FA in general phospholipids and plasmalogenic microsomal membranes depending on their functions was found under EFA deficit in the organism. Deficit of DHA and plasmalogenic phospholipids evidences that the status of cell plasmalogens affects the level of PUFA at EFA deficit in the organism. AA and DHA can be a selective target for plasmalogens. The drug of omega-3 phospholipids, considerable amount of DHA and eicosapentaenoic (EPA)FA being present in their structure, increases the amount of plasmalogens and decreases the amount of AA in the brain, heart and reproductive organs. It was also found that EFA deficit in the organism favours the increase of lisoPEA, lisoPC, free FA (FFA) connected with the increase of activity of endogenic phospholippase A2 and plasmalogen-selective phospholipase A2. The omega-3 phospholipase from marine organisms at EFA defecit decreases the amount of FFA, lisophospholipids and activity of phospholipase A2 in the microsomas of the studied tissues. The drug of omega-3 phospholipids normalizes the state and functions of the brain, liver, and heart tissues, reproductive organs against a background of EFA defecit and regulates the synthesis of biologocically active metabolites of AA in the organism.